⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2645734 | 1.00 | — | — | |
| SCHEMBL1371626 | 1.00 | — | — | |
| SCHEMBL1055495 | 1.00 | — | — | |
| SCHEMBL6687479 | 1.00 | — | — | |
| SCHEMBL5131181 | 1.00 | — | — | |
| SCHEMBL2645580 | 1.00 | — | — | |
| SCHEMBL2645578 | 1.00 | — | — | |
| SCHEMBL3678625 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL3974504 | 0.98 | DPP4 (0.42) | — | |
| Hydrochloric Acid SCHEMBL9834698 | 0.98 | DPP4 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4736945-A2 | AMYLIN ANALOGUES | Zealand Pharma A/S (DK) | 2026-05-06 | — | — | EP | claimed |
| EP-4736946-A2 | AMYLIN ANALOGUES | Zealand Pharma A/S (DK) | 2026-05-06 | — | — | EP | claimed |
| EP-4735021-A1 | COMBINATION THERAPY | Zealand Pharma A/S (DK) | 2026-05-06 | — | — | EP | claimed |
| US-12616737-B2 | Liquid formulations of amylin analogues | ZEALAND PHARMA A/S (DK) | 2026-05-05 | — | — | US | claimed |
| EP-4731239-A1 | ANALOGUES WITH IMPROVED PROPERTIES | Zealand Pharma A/S (DK) | 2026-04-29 | — | — | EP | claimed |
| EP-4074729-B1 | AMYLIN ANALOGUES | ZEALAND PHARMA AS (DK) | 2026-04-15 | — | — | EP | claimed |
| EP-4590326-A1 | COMBINATION THERAPY | Zealand Pharma A/S (DK) | 2025-07-30 | — | — | EP | claimed |
| CN-120040558-A | Polypeptides or analogues thereof and uses thereof | 深圳湾实验室 | 2025-05-27 | — | — | CN | claimed |
| CN-119923269-A | Combination therapy | 西兰制药公司 | 2025-05-02 | — | — | CN | claimed |
| US-20250064895-A1 | AMYLIN ANALOGUES | ZEALAND PHARMA A/S (DK) | 2025-02-27 | — | — | US | claimed |
| CN-114904577-A | Chiral porous cross-linked oligopeptide polymer asymmetric catalyst and preparation method thereof | 哈尔滨工程大学 | 2022-08-16 | — | — | CN | claimed |
| US-11382956-B2 | Amylin analogues | ZEALAND PHARMA A/S (DK) | 2022-07-12 | — | — | US | claimed |
| EP-3898631-A1 | NOVEL IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIALS | F. Hoffmann-La Roche AG (CH) | 2021-10-27 | — | — | EP | claimed |
| WO-2020126953-A1 | NOVEL IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIALS | F. HOFFMANN-LA ROCHE AG (CH) | 2020-06-25 | — | — | WO | claimed |
| CN-109044921-A | One kind is anti-ageing to convey nano-lipid vesica and its preparation method and application altogether | 武汉百思凯瑞生物科技有限公司 | 2018-12-21 | — | — | CN | claimed |
| EP-2291359-A1 | PHENYL OR PYRIDINYL SUBSTITUTED INDAZOLES DERIVATIVES | AstraZeneca AB (SE) | 2011-03-09 | — | — | EP | claimed |
| US-20100080786-A1 | Phenyl or Pyridinyl Substituted Indazoles Derivatives | ASTRAZENECA AB (SE) | 2010-04-01 | — | — | US | claimed |
| WO-2009142569-A1 | PHENYL OR PYRIDINYL SUBSTITUTED INDAZOLES DERIVATIVES | ASTRAZENECA AB (SE) | 2009-11-26 | — | — | WO | claimed |
| EP-0804465-A1 | NOVEL ELASTASE INHIBITORS | HOECHST MARION ROUSSEL, INC. (US) | 1997-11-05 | — | — | EP | claimed |
| US-3932638-A | Compositions and methods for wound healing | FRANCO-CHIMIE S.A.R.L. (FR) | 1976-01-13 | — | — | US | claimed |